期刊文献+

长沙地区反应性献血者归队情况回顾性分析

Reentry of reactive blood donors in Changsha area:a retrospective analysis
下载PDF
导出
摘要 目的 对本中心单试剂反应性献血者主动归队情况进行分析,为主动召回单试剂反应性献血者提供数据支持和参考。方法 从本中心启奥采供血信息系统中采集2019年1月—2023年9月符合归队条件的献血者信息,对其主动归队情况进行追踪和回顾性分析。统计符合归队条件献血者主动归队人口统计学特征、主动归队率,再次献血率,采用χ^(2)检验比较归队合格率之间的差异以及影响再次献血的因素。结果 符合归队条件的献血者共3 361名,主动归队率为2.7%(91/3 361),归队合格率为80.21%(73/91)。不同性别、学历、献血次数、检测项目、献血类型的符合归队条件献血者的归队率(3.3%vs 2.1%;3.7%vs 2.3%;9.3%vs 4.0%vs 1.3%;7.7%vs 2.7%vs 1.9%vs 1.3%;18.1%vs 2.0%)比较均有差异(P<0.05)。不同年龄段的献血者归队合格率(61.1%vs 94.4%vs 81.8%)比较有差异(P<0.05)。献血者再次献血共126人次,共献血47 800 mL,再次献血率为49.3%(36/73),再次献血合格率98.4%(124/126),再次献血者与首次献血者的献血类型比较有差异(P<0.05)。结论 本中心单试剂反应性献血者主动归队率较低,但归队合格率和再次献血率均较高,再次献血方式以单采献血为主,归队成功的献血者献血意愿强烈。 Objective To analyze the reentry of single reagent reactive voluntary blood donors in our center,in order to provide data support and reference for the recall of single reagent reactive blood donors.Methods Collect the information of eligible blood donors from the information system of our center from January 2019 to September 2023 were collected,and the reentry were tracked and retrospectively analyzed.The demographic characteristics,active reentry rate,and re-donation rate of eligible blood donors were analyzed,and the differences between qualified reentry rates and factors affecting re-donation were compared using chi-square test.Results A total of 3361 blood donors met the reentry criteria,with an active reentry rate of 2.7%(91/3361)and a qualified reentry rate of 80.21%(73/91).The reentry rate of eligible blood donors showed significant differences in terms of different genders(3.3%vs 2.1%),educational background(3.7%vs 2.3%),blood donation frequency(9.3%vs 4.0%vs 1.3%),testing items(7.7%vs 2.7%vs 1.9%vs 1.3%)and blood donation types(18.1%vs 2.0%)(P<0.05).Difference was noticed in the qualified rate of blood donor reentry among different age groups(61.1%vs 94.4%vs 81.8%)(P<0.05).A total of 126 blood donors donated again,with a total volume of 47800 mL,a re-donation rate of 49.3%(36/73)and a qualified rate of re-donation of 98.4%(124/126),showing a difference between repeat blood donors and first-time donors(P<0.05).Conclusion The active reentry rate of single reagent reactive blood donors in our center is relatively low,but the qualified rate of reentry and the re-donation rate are both high.The re-donation is mainly donation of apheresis platelets,and successful reentry blood donors have a strong willingness to donate blood.
作者 李尚武 康甜 袁媛 罗佳 LI Shangwu;KANG Tian;YUAN Yuan;LUO Jia(Changsha Blood Center,Changsha 410000,China;Hunan Normal University)
出处 《中国输血杂志》 CAS 2024年第4期444-448,共5页 Chinese Journal of Blood Transfusion
关键词 反应性献血者归队 假反应性 血液安全 无偿献血 reentry of reactive blood donors false reactivity blood safety voluntary blood donation
  • 相关文献

参考文献10

二级参考文献68

  • 1刘宇宁,伍晓菲,贾尧,蔡菊英,刘晓音,王迅.乙型肝炎病毒表面抗原血液复查阳性结果确认方案的研究[J].临床输血与检验,2011,13(4):303-306. 被引量:18
  • 2Tynell E. Norda R, Ekermo B, et al. False-reactive microbiologic screening test results in Swedish blood donors-how big is the problem? A survey among blood centers and deferred donors. Trans- fusion,2007,47( 1 ) :80-89.
  • 3Whittaker S, Carter N, Arnold E, et al. Understanding the meaning of permanent deferral for blood donors. Transfusion , 2008 , 48 ( 1 ) : 64-72.
  • 4FDA. Recommendations for the management of donors and units that are initially reactive for hepatitis B surface antigen ( HBsAg), 1987-12-02.
  • 5FDA. Guidance for industry, nucleic acid testing (NAT) for human immunodeficiency virus type 1 (HIV-1) and hepatitis C virns (HCV) :testing,product disposition, and donor defen'al anti reen- try,2010-05.
  • 6FDA Guidance for Industry. Use of nucleic acid'ests on pooled and individual samples from donors of whole blood and blood compo- nents, including source plasma, to reduce the risk of transmiion of hepalitis B virus,2012-10.
  • 7FDA Guidance for Industry. Requalification method for reentry, ofblood donors deferred because of reactive test results fro: antibxly to hepatitis B core antigen (Anti-HBc) ,2010-05.
  • 8Scheiblauer H,El-Nageh M,Diaz S,et al. Performance evaluation of 70 hepatitis B virus (HBV) surfaceantigen (HBsAg)assays from around the world by ageographically diverse panel wiih an array of HBV genotypasand HBsAg subtypes. Vox Sang,2010,98(3) :403- 414.
  • 9中华人民共和国卫生部医政司.金国临床检验操作规程(第3版).南京:东南大学出版社,2006:626.
  • 10Candido A, Chionne P, Milazzo L, et al. Nucleic acid testing (NAT) for HCV RNA in Italian transfusioncentre:: an external quality assessment. J Clin Virol,2008,41 (4) :277'-282.

共引文献78

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部